5.100
−15,00%
2026-10-16
Fundamental Analysis
52 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -47.2% | +46.6% | 2 / 3 | +60.5% | -6.87 pp | -6.43 pp | +7.1% | 0.09 | 10.70 | 41,9 | +60,5% | 1,3 | −47,2% | 10.70 | 15.03 | −28,8% |
| Pts | 0 | 12 | 8 | 12 | 0 | 0 | 0 | 12 | 12 | |||||||
Valuation annotation:Price: 5.100 (close price on 2026-10-16)EPS (TTM): 476,8
Financial charts
1.Revenue & growth
VND bn41,9Q2/26
1.Revenue & growth
VND bn41,9Q2/26
2.Profit & growth
VND bn1,32Q2/26
3.Profit mix (Penman)
VND bn9,95Q2/26
4.Margins & cost structure
%22.7%Q2/26
5.Returns & cash cycle
% · days8.4%Q2/26
6.Earnings quality & cash
VND bn14,6Q2/26
7.Asset structure
VND bn168Q2/26
8.Funding & debt health
VND bn · times168Q2/26
9.Revenue backlog
VND bn0,25Q2/26
10.Valuation
times · %10,7×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %81Q2/26
Adjusted EPS growth, latest quarter
-47.2%
Average adjusted EPS growth, 3 quarters
46.6%
Quarters at 25%+ growth
2/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26